Operational Efficiency Prepares You For Growth and M&A

Operational Efficiency Prepares You For Growth and M&A

When the market shows signs of growth, the first thing you might think to do is double down on selling your products. And that makes sense. But there are other things you should do, such as spending some time reviewing your operations and ensuring you have the right processes and technology to support the increase in demand you are expecting.

The other thing you should be thinking about is the potential for M&A.

Both the MENA region and Latin America show signs of immense growth opportunity:

  • MENA has a market size exceeding USD 40 billion and has seen an average annual growth rate of approximately 7-9% over the past decade.
  • The Latin American market grew from US$34.3 billion in 2008 to US$69.5 billion in 2018 and accounts for 6.3 percent of the world’s pharmaceutical market value.

In both cases, M&A is getting a lot of attention. And with the possibility of increased M&A activity on the horizon, every pharmaceutical company operating in MENA and Latin America has the power to be proactive in preparing for potential M&A events.

We covered the reasons you should be thinking about M&A - whether you are the one acquiring another company or the one being acquired. You can check out those blogs here:


Is Your Digital Transformation Strategy Stuck in First-Gear?

Many mid-sized Pharmaceutical companies in the Middle East and Northern Africa (MENA) believe that they have a huge opportunity to grow and advance their businesses with the right investments in technology.?

Deciding which technologies you need and when is one of the hardest decisions to make. We hope this guide will help you.??

Download the guide here to help you get started.


About Scigeniq

We are deeply committed to helping customers leverage world-class software solutions to drive dramatic improvements in quality, regulatory, and content-management processes. You can check out our full suite of quality, training, document management, and regulatory solutions to automate and optimize end-to-end processes and deliver maximum impact. With decades of experience with some of the largest and best-known pharma companies in the region, we work hard to bring best practices and a pragmatic perspective to every customer’s implementation of their solutions.


If you like what you are reading, please share this newsletter with your colleagues so they can enjoy the same valuable information.


Loubna Lamrani

Grands Projets/Performance/Transformation/Audit ENPC MBA Alumni /ISCAE Alumni

10 个月

Very interesting!

要查看或添加评论,请登录

Scigeniq的更多文章

社区洞察

其他会员也浏览了